Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-02-19

Clinical Trial Update: Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of benfotiamine (a thiamine derivative) on endothelial function in people with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benfotiamine (benfotiamine)

Snippet

Sponsor: Ruhr University of Bochum | Conditions: Endothelial Dysfunction, Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED